Clinical Trials Browser

OTHER × Unspecified Adult Solid Tumor, Protocol Specific × Bortezomib × Clear all

NCT00023855 2019-12-13

PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00290680 2018-04-10

Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00541359 2017-08-09

Bortezomib and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific